Tinea incognito in Italy: a 15-year survey

C Romano1, E Maritati, C Gianni

  • 1Institute of Dermatological Sciences, University of Siena, Via Monte Santo 3, 53100 Siena, Italy. mondelli@unisi.it

Mycoses
|August 23, 2006
PubMed

Insights

Steroid-modified tinea (tinea incognito) presents atypical symptoms, mimicking various skin conditions due to prior misdiagnosis or treatment. Effective antifungal therapy generally leads to recovery, except in rare cases of immunodepression.

Area of Science:

  • Dermatology
  • Mycology
  • Infectious Diseases

Background:

  • Tinea incognito, or steroid-modified tinea, is a fungal infection altered by steroid use.
  • Steroids are often administered due to misdiagnosis or pre-existing conditions, changing the typical ringworm appearance.
  • This modification can cause the fungal infection to mimic other dermatological diseases.

Purpose of the Study:

  • To analyze the causative agents, clinical presentations, and sources of infection in tinea incognito.
  • To understand the epidemiological and clinical characteristics of this steroid-modified fungal infection.

Main Methods:

  • A retrospective study of 200 cases of tinea incognito observed in Siena and Milan, Italy (1987-2002).
  • Identification of fungal agents through mycological examination.
  • Analysis of clinical data, including appearance and affected body areas.

Main Results:

  • The most frequently isolated agents were Trichophyton rubrum and Trichophyton mentagrophytes.
  • Clinical presentations varied, mimicking conditions like lupus erythematosus, eczema, rosacea, impetigo, psoriasis, and lichen planus.
  • Folliculitis occurred in 9% of cases, and dermatophytid reactions in 3%.

Conclusions:

  • Tinea incognito presents with diverse clinical features, often misdiagnosed.
  • Prompt antimycotic therapy is effective for clinical and mycological resolution in most cases.
  • Iatrogenic immunodepression is a rare complication that can hinder recovery.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...